American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S328-S332 , December 2008

The clinical content of preconception care: women with psychiatric conditions

  • Ariela Frieder, MD

      Affiliations

    • Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
    • Corresponding Author InformationReprints: Ariela Frieder, MD, Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, 111 East 210th St., Bronx, NY 10467
    • ,
  • Anne L. Dunlop, MD, MPH

      Affiliations

    • Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA
    • ,
  • Larry Culpepper, MD, MPH

      Affiliations

    • Department of Family Medicine, Boston University School of Medicine, Boston, MA
    • ,
  • Peter S. Bernstein, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Received 17 June 2008 ,Revised 29 August 2008 ,Accepted 3 September 2008.

References 

  1. Burt VK, Hendrick VC. Clinical manual of women's mental health. In:  Wyszynski AA,  Wyszynski B editor. Manual of psychiatric care for the medically ill. Arlington, VA: American Psychiatric Publishing, Inc; 2005;
  2. Cohen LS, Nonacs RM. Mood and anxiety disorders during pregnancy and postpartum (Review of psychiatry, volume 24). In:  Wyszynski AA,  Wyszynski B editor. Manual of psychiatric care for the medically ill. Arlington, VA: American Psychiatric Publishing, Inc; 2005;
  3. Brockington I. Motherhood and mental health. New York, NY: Oxford University Press; 1996;
  4. Wyszynski AA, Lusskin S. The obstetric patient. In:  Wyszynski AA,  Wyszynski B editor. Manual of psychiatric care for the medically ill. Arlington, VA: American Psychiatric Publishing, Inc; 2005;
  5. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry. 2006;67:8
  6. Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight and postpartum depression—the need for interdisciplinary integration. Am J Obstet Gynecol. 2005;193:1312–1322
  7. Brockington I. Postpartum psychiatric disorders. Lancet. 2004;363:303–310
  8. Davis EP, Glynn LM, Schetter CD, Hobel C, Chicz-Demet A, Sandman CA. Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry. 2007;46:737–746
  9. Talge NM, Neal C, Glover V. Early Stress, Translational Research and Prevention Science Network: fetal and Neonatal Experience on child and Adolescent Mental Health (Antenatal maternal stress and long term effects on child neurodevelopment: how and why?). J Child Psychol Psychiatry. 2007;48:245–261
  10. Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry. 2006;28:1–2
  11. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004;26:289–295
  12. Monk C. Stress and mood disorders during pregnancy: implications for child development. Psychiatric Quarterly. 2001;72:347–357
  13. Davis EP, Snidman N, Wadhwa PD, Glynn LM, Schetter CD, Sandman CA. Prenatal maternal anxiety and depression predict negative behavioral reactivity in infancy. Infancy. 2004;6:319–331
  14. Brockington IF, Macdonald E, Wainscott G. Anxiety, obsessions and morbid preoccupations in pregnancy and the puerperium. Arch Womens Ment Health. 2006;9:253–263
  15. Loveland Cook CA, Flick LH, Homan SM, Campbell C, McSweeney M, Gallagher ME. Posttraumatic stress disorder in pregnancy: prevalence, risk factors, and treatment. Obstet Gynecol. 2004;103:710–717
  16. Diagnostic and statistical manual of mental disorders (Text revision). Fourth edition. Arlington, VA: American Psychiatric Association; 2000;
  17. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004;26:289–295
  18. Schulberg HC, Raue PJ, Rollman BL. The effectiveness of psychotherapy in treating depressive disorders in primary care practice: clinical and cost perspectives. Gen Hosp Psychiatry. 2002;24:203–212
  19. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry. 1994;45:444–450(Level III)
  20. Rabheru K. The use of elelctroconvulsive therapy in special patient populations. Can J Psychiatry. 2001;46:710–719(Level III)
  21. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198:191.e1–191.e5
  22. Altshuler LL, Cohen LS, Szuba MP, Burt VK, Fitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry. 1996;153:392–606
  23. Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy. JAMA. 1999;282:1264–1269
  24. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356:2684–2692
  25. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. First-trimester use of selective serotonin reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356:2675–2683
  26. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;64:898–906
  27. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164:1206–1213
  28. Chambers CD, Hernandez-Diaz S, VanMarter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579–587
  29. Kahn D. Moline ML, Ross RW, Cohen LS, Altshuler LL. Major depression during conception and pregnancy: a guide for patients and families. Expert Consensus Guideline Series. March 2001.
  30. Freeman MP. Antenatal depression: navigating the treatment dilemmas. Am J Psychiatry. 2007;164:1162–1165
  31. Cohen LS, Nanacs RM, Bailey JW, et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Womens Ment Health. 2004;7:217–221
  32. Viguera AC, Cohen LS, Bouffard S, Whitfield TH, Baldessarini RJ. Reproductive decisions by women with bipolar disorder after pre pregnancy psychiatric consultation. Am J Psychiatry. 2002;159:2102–2104
  33. Merikangas KR, Low NC. The epidemiology of mood disorders. Curr Psychiatry Rep. 2004;6:411–421
  34. Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161:608–620
  35. Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164:1817–1824
  36. Stewart DE, Klompenhouwer JL, Kendell RE, Van Hulst AM. Prophylactic lithium in puerperal psychosis (The experience of three centers). Br J Psychiatry. 1991;158:393–397
  37. Cohen LS. Treatment of bipolar disorder during pregnancy. J Clin Psychiatry. 2007;68(suppl 9):4–9
  38. Shor S, Koren G, Nulman I. Teratogenicity of lamotrigine. Can Fam Physician. 2007;53:1007–1009
  39. Viguera AC, Koukopoulos A, Muzina DJ, Baldessarini RJ. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry. 2007;68(suppl 9):29–33
  40. Jones I, Craddock N. Bipolar disorder and childbirth: the importance of recognizing risk. Br J Psychiatry. 2005;186:453–454
  41. Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry. 2002;47:426–436
  42. Gentil S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disorders. 2006;8:207–220
  43. Yaeger D, Smith HG, Altshuler LL. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and postpartum. Am J Psychiatry. 2006;163:2064–2070
  44. Patton SW, Misri S, Corral MR. Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can J Psychiatry. 2002;47:959–965

 Conflict of Interest: Ariela Frieder, MD; Anne L. Dunlop, MD, MPH; and Peter S. Bernstein, MD, MPH have no conflict of interest including grants, honoraria, advisory board membership, or share holdings. Larry Culpepper, MD, MPH is a consultant or is on the advisory board of Forest Labs, New York, NY; Pfizer, New York, NY; Wyeth, Madison, NJ; AstraZeneca, Wilmington, DE; Lilly, Indianapolis, IN; and Cephalon, Frazer, PA. He is on a Speakers Bureau for Forest Labs, Pfizer, and Wyeth.

PII: S0002-9378(08)01039-9

doi: 10.1016/j.ajog.2008.09.001

American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S328-S332 , December 2008

Article Tools